A virus-neutralizing epitope on the glycoprotein of rabies virus that contains Trp251 is a linear epitope

Virus Research

Volumn 51, Issue 1, 1997, Pages 35-41

  Luo, Ting Rong ^a   Minamoto, Nobuyuki ^a   Ito, Hiroshi ^a   Goto, Hideo ^a   Hiraga, Shinya ^a   Ito, Naoto ^a   Sugiyama, Makoto ^a   Kinjo, Toshio ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Glycoprotein; Linear epitope; Monoclonal antibody; Rabies virus

Indexed keywords

EPITOPE; NEUTRALIZING ANTIBODY; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; HUMAN CELL; HYBRIDOMA; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; RABIES VIRUS;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; EPITOPES; GLYCOPROTEINS; GTP-BINDING PROTEINS; MICE; MICE, INBRED BALB C; MUTAGENESIS, SITE-DIRECTED; NEUTRALIZATION TESTS; POINT MUTATION; RABIES VIRUS; SEQUENCE ANALYSIS, DNA; TRYPTOPHAN; VARIATION (GENETICS);

RABIES VIRUS; SIMIAE;

EID: 0031238778     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(97)00080-4     Document Type: Article

References (28)

1. Bai, X., Warner, C.K., Fekadu, M., 1993. Comparisons of nucleotide and deduced amino acid sequences of the glycoprotein genes of a Chinese street strain (CGX89-1) and a Chinese vaccine strain (3aG) of rabies virus. Virus Res. 27, 101-112.
2. Benmansour, A., Leblois, H., Coulon, P., Tuffereau, C., Gaudin, Y., Flamand, A., Lafay, F., 1991. Antigenicity of rabies virus glycoprotein. J. Virol. 65, 4189-4203.
3. Conzelmann, K.K., Cox, J.H., Schneider, L.G., Thiel, H.I., 1990. Molecular cloning and complete nucleotide sequence of attenuated rabies virus SAD B19. Virology 175, 485-499.
4. Dietzschold, B., Gore, M., Marchadire, D., Niu, H.S., Bunschoten, H.M., JR, L.O., Wunner, W.H., Ertl, H.C.J., Osterhaus, A.D.M.E., Koprowski, H., 1990. Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine. J. Virol. 64, 3804-3809.
5. Flamand, A., Wiktor, T.J., Koprowski, H., 1980. Use of hybridoma monoclonal antibodies in the detection of antigenic differences between rabies and rabies-related virus protein II. The glycoprotein. J. Gen. Virol. 48, 105-109.
6. Flamand, A., Raux, H., Gaudin, Y., Ruigrok, R.W.H., 1993. Mechanisms of rabies virus neutralization. Virology 194, 302-313.
7. Goto, H., Minamoto, N., Ito, H., Sugiyama, M., Kinjo, T., Mannen, K., Mifune, K., Kawai, A., 1994. Nucleotide sequence of the nucleoprotein gene of the RC-HL strain of rabies virus, a seed strain used for animal vaccine production in Japan. Virus Genes 8, 91-97.
8. Heijden, R.W.J., Langedijk, J.P.M., Groen, J., Uytdehaad, F.G.C.M., Meloen, R.H., Osterhaus, A.D.M.E., 1993. Structural and functional studies on a unique linear neutralizing antigenic site (G5) of the rabies virus glycoprotein. J. Gen. Virol. 49, 1539-1545.
9. Ito, H., Minamoto, N., Goto, H., Luo, T.R., Sugiyama, M., Kinjo, T., 1996. Expression of the major inner capsid protein, VP6, of avian rotavirus in mammalian cells. Vet. Microbiol. 49, 257-265.
10. Ito, H., Minamoto, N., Watanabe, T., Goto, H., Luo, T.R., Sugiyama, M., Kinjo, T., Mannen, K., Mifune, K., Konobe, T., Yoshida, I., Takamizawa, A., 1994. A unique mutation of glycoprotein gene of the attenuated RC-HL strain of rabies virus, a seed virus used for production of animal vaccine in Japan. Microbiol. Immunol. 38, 479-482.
11. Lafay, F., Benmansour, A., Chebli, K., Flamand, A., 1996. Immunodominant epitopes denned by a yeast-expressed library of random fragments of the rabies virus glycoprotein map outside major antigenic sites. J. Gen. Virol. 77, 339-346.
12. Lafon, M., Idleler, J., Wunner, W.H., 1991. Investigation of the antigenic structure of rabies virus glycoprotein by monoclonal antibodies. Dev. Biol. Stand. 57, 219-225.
13. Lafon, M., Wiktor, T.J., Macfarlan, R.I., 1983. Antigenic sites on the CVS rabies virus glycoprotein: analysis with monoclonal antibodies. J. Gen. Virol. 64, 843-851.
14. Minamoto, N., Tanaka, H., Hishita, M., Goto, H., Ito, H., Naruse, S., Yamamoto, Y., Sugiyama, M., Kinjo, T. Mannen, K., Mifune, K., 1994. Linear and conformation-dependent antigenic sites on the nucleoprotein of rabies virus. Microbiol. Immunol. 38, 449-455.
15. Morimoto, K., Patel, M., Corisdeo, S., Hooper, D.C., Fu, Z.F., Rupprecht, C.E., Koprowski, H., Dietzschold, B., 1996. Characterization of a unique variant of bat rabies virus responsible for newly emerging human cases in North America. Proc. Natl. Acad. Sci. USA 93, 5653-5658.
16. Nadin-Davis, S.A., Casey, G.A., Wandeler, A.I., 1994. A molecular epidemiological study of rabies virus in central Ontario and western Queec. J. Gen. Virol. 75, 2575-2583.
17. Ni, Y., Tominaga, Y., Honda, Y., Morimoto, K., Sakamoto, S., Kawai, A., 1995. Mapping and characterization of a sequential epitope on the rabies virus glycoprotein which is recognized by a neutralizing monoclonal antibody, Rg719. Microbiol. Immunol. 39, 693-702.
18. Prehaud, C., Coulon, P., Lafay, F., Thiers, C., Flamand, A., 1988. Antigenic site II of the rabies virus glycoprotein: structure and role in viral virulence. J. Virol. 62, 1-7.
19. Raux, H., Coulon, P., Lafay, F., Flamand, A., 1995. Monoclonal antibodies which recognize the acidic configuration of the rabies glycoprotein at the surface of the virion can be neutralizing. J. Virol. 210, 400-408.
20. Sakamoto, S., Ide, T., Nakatake, H., Tokiyoshi, S., Yamamoto, M., Kawai, A., Smith, J.S., 1994. Studies on the antigenicity and nucleotide sequence of the rabies virus Nishigahara strain, a current seed strain used for dog vaccine production in Japan. Virus Genes 8, 35-46.
21. Sanger, F., Nicklen, S., Coulson, A.R., 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74, 5463-5467.
22. Seif, I., Coulon, P., Rollin, P.E., Flamand, A., 1985. Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutation affecting antigenic site III of the glycoprotein. J. Virol. 53, 926-934.
23. Takebe, Y., Seiki, M., Fujisawa, J-I., Hoy, P., Yokota, K., Arai, K-I., Yoshita, M., Arai, N., 1988. SRα promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of Human T-cell leukemia virus type 1 long terminal repeat. Mol. Cell, Biol. 8, 466-472.
24. Tuffereau, C., Leblois, H., Benejean, J., Coulon, P., Lafay, F., Flamand, A., 1989. Arginine or lysine in position 333 of ERA and CVS glycoprotein is necessary for rabies virulence in adult mice. Virology 172, 206-212.
25. Wiktor, T.J., Gyorgy, E., Schlumberger, H.D., Sokol, F., Koprowski, H., 1973. Antigenic properties of rabies virus components. J. Immunol. 110, 269-276.
26. Wiktor, T.J., Koprowski, H., 1980. Antigenic variants of rabies virus. J. Exp. Med. 152, 99-112.
27. Wunner, W.H., Dietzschold, B., Smith, C.L., Lafon, M., Golub, E., 1985. Antigenic variants of CVS rabies virus with altered glycosylation site. Virology 140, 1-12.
28. Wunner, W.H., Reagan, K.J, Koprowski, H., 1984. Characterization of saturable binding sites for rabies virus. J. Virol. 50, 691-697.